We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cocrystal Pharma Inc | NASDAQ:COCP | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.06 | 3.92% | 1.59 | 1.50 | 1.65 | 1.59 | 1.52 | 1.53 | 17,031 | 23:31:55 |
From May 2019 to May 2024
The live presentation will be available at www.noblecon17.com. A high-definition video webcast of the presentation will be available beginning January 20, 2021 on the Investors section of the Cocrystal website here.
Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, hepatitis C viruses, coronaviruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.
Investor Contact:LHA Investor RelationsJody Cain310-691-7100jcain@lhai.com
# # #
1 Year Cocrystal Pharma Chart |
1 Month Cocrystal Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
